These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28214961)

  • 21. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renal consequences of obesity].
    Laville M
    Nephrol Ther; 2011 Apr; 7(2):80-5. PubMed ID: 21208837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and kidney disease: potential mechanisms.
    Wickman C; Kramer H
    Semin Nephrol; 2013 Jan; 33(1):14-22. PubMed ID: 23374890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity.
    Chade AR; Hall JE
    Am J Nephrol; 2016; 44(5):354-367. PubMed ID: 27771702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood Obesity and the Metabolic Syndrome.
    Nehus E; Mitsnefes M
    Pediatr Clin North Am; 2019 Feb; 66(1):31-43. PubMed ID: 30454749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Obesity and kidney disease - renal consequences of an "epidemic"].
    Schiffl H; Lang SM
    Dtsch Med Wochenschr; 2017 Sep; 142(19):1466-1472. PubMed ID: 28938511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The number of metabolic syndrome components is a good risk indicator for both early- and late-stage kidney damage.
    Okada R; Yasuda Y; Tsushita K; Wakai K; Hamajima N; Matsuo S
    Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):277-85. PubMed ID: 24418372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Obesity in children and its relationship with chronic kidney disease].
    Zurita-Cruz JN; Villasís-Keever MÁ
    Rev Med Inst Mex Seguro Soc; 2016; 54(4):514-20. PubMed ID: 27197109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity-related renal injury in childhood.
    Savino A; Pelliccia P; Chiarelli F; Mohn A
    Horm Res Paediatr; 2010; 73(5):303-11. PubMed ID: 20389099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity in CKD--what should nephrologists know?
    Stenvinkel P; Zoccali C; Ikizler TA
    J Am Soc Nephrol; 2013 Nov; 24(11):1727-36. PubMed ID: 24115475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of obesity-induced kidney disease: a critical review of the literature.
    Kiortsis DN; Christou MA
    Obes Facts; 2012; 5(6):821-32. PubMed ID: 23207569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal relationships of metabolic syndrome and obesity with kidney function: Healthy Twin Study.
    Song YM; Sung J; Lee K
    Clin Exp Nephrol; 2015 Oct; 19(5):887-94. PubMed ID: 25634252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood Obesity and Impact on the Kidney.
    Correia-Costa L; Azevedo A; Caldas Afonso A
    Nephron; 2019; 143(1):8-11. PubMed ID: 30359981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity and CKD progression: hard facts on fat CKD patients.
    Mallamaci F; Tripepi G
    Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv105-8. PubMed ID: 24179007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Offspring body size and metabolic profile - effects of lifestyle intervention in obese pregnant women.
    Tanvig M
    Dan Med J; 2014 Jul; 61(7):B4893. PubMed ID: 25123127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of risk factors for chronic kidney disease among adults in a university community in southern Nigeria.
    Wachukwu CM; Emem-Chioma PC; Wokoma FS; Oko-Jaja RI
    Pan Afr Med J; 2015; 21():120. PubMed ID: 26327957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal resistive index and parathyroid hormone relationship with renal function in nondiabetic patients.
    Trovato GM; Martines GF; Trovato FM; Pirri C; Pace P; Catalano D
    Endocr Res; 2012; 37(2):47-58. PubMed ID: 22007967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects.
    Brown RN; Mohsen A; Green D; Hoefield RA; Summers LK; Middleton RJ; O'Donoghue DJ; Kalra PA; New DI
    Nephrol Dial Transplant; 2012 Jul; 27(7):2776-80. PubMed ID: 22442391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of obesity and chronic kidney disease.
    Ross WR; McGill JB
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):325-35. PubMed ID: 17045219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.